ADMA BIOLOGICS, INC. Restricted Cash and Cash Equivalents, Noncurrent
ADMA BIOLOGICS, INC. (ADMA) had Restricted Cash and Cash Equivalents, Noncurrent of $0 as of 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2019-11-06
- 2019-09-30: Restricted Cash and Cash Equivalents, Noncurrent $0.00.
- 2019-06-30: Restricted Cash and Cash Equivalents, Noncurrent $0.00.
- 2019-03-31: Restricted Cash and Cash Equivalents, Noncurrent $0.00.
- 2018-12-31: Restricted Cash and Cash Equivalents, Noncurrent $4.00M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 |
| 2018-12-31 | $4.00M 10-Q · filed 2019-11-06 |
| 2018-09-30 | $4.00M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $4.00M 10-Q · filed 2018-08-10 |
| 2018-03-31 | $4.00M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $4.00M 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |